Franklin Genomic Advancements ETF (HELX)

BATS: HELX · Real-Time Price · USD
33.13
-0.50 (-1.50%)
At close: Apr 28, 2026, 4:00 PM EDT
33.13
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
-1.50%
Assets $21.87M
Expense Ratio 0.50%
PE Ratio 29.27
Shares Out 650,000
Dividend (ttm) $0.14
Dividend Yield 0.43%
Ex-Dividend Date Dec 30, 2025
Payout Ratio 12.28%
1-Year Return n/a
Volume 128
Open 33.13
Previous Close 33.63
Day's Range 33.13 - 33.13
52-Week Low n/a
52-Week High n/a
Beta 1.09
Holdings 65
Inception Date Feb 25, 2020

About HELX

Fund Home Page

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is issued by Franklin Templeton.

Asset Class Equity
Category Health
Region Global
Stock Exchange BATS
Ticker Symbol HELX
ETF Provider Franklin Templeton

Top 10 Holdings

44.13% of assets
Name Symbol Weight
Natera, Inc. NTRA 6.59%
Guardant Health, Inc. GH 6.35%
Krystal Biotech, Inc. KRYS 5.44%
United Therapeutics Corporation UTHR 4.42%
BridgeBio Pharma, Inc. BBIO 4.02%
Ligand Pharmaceuticals Incorporated LGND 3.99%
Insmed Incorporated INSM 3.92%
AstraZeneca PLC AZN 3.27%
Adaptive Biotechnologies Corporation ADPT 3.07%
Samsung Biologics Co.,Ltd. 207940 3.06%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 30, 2025 $0.14334 Jan 8, 2026
Dec 30, 2021 $0.00394 Jan 7, 2022
Dec 13, 2021 $0.11415 Dec 21, 2021
Dec 14, 2020 $0.05178 Dec 23, 2020
Full Dividend History

News

There is no news available yet.